WITHDRAWAL FROM HEMODIALYSIS: A PATIENT DECIDESULAN RA; MAI FM; BURLEY J et al.1983; DIALYSIS & TRANSPLANTATION; ISSN 0090-2934; USA; DA. 1983; VOL. 12; NO 5; PP. 397-400; 3 P.; BIBL. 9 REF.Article

FIBROUS HYPERPLASIA OF THE GINGIVA: A SIDE EFFECT OF CYCLOSPORIN A THERAPY = HYPERPLASIE FIBREUSE DE LA GENCIVE: UN EFFET SECONDAIRE DU TRAITEMENT PAR LA CYCLOSPORINE AWYSOCKI GP; GRETZINGER HA; LAUPACIS A et al.1983; ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY; ISSN 0030-4220; USA; DA. 1983; VOL. 55; NO 3; PP. 274-278; ABS. ENG; BIBL. 22 REF.; FIGArticle

CHRONIC PLASMA EXCHANGE THERAPY IN SLE NEPHRITISCLARK WF; LINDSAY RM; ULAN RA et al.1981; CLIN. NEPHROL.; ISSN 0301-0430; DEU; DA. 1981; VOL. 16; NO 1; PP. 20-23; BIBL. 26 REF.Article

EFFECTS OF CHRONIC HEMODIALYSIS ON THYROID FUNCTION IN CHRONIC RENAL FAILURE = EFFETS DE L'HEMODIALYSE PERIODIQUE SUR LA FONCTION THYROIDIENNE DANS L'INSUFFISANCE RENALE CHRONIQUESILVERBERG DS; ULAN RA; FAWCETT DM et al.1973; CANAD. MED. ASS. J.; CANADA; DA. 1973; VOL. 109; NO 4; PP. 282-286; BIBL. 36REF.Article

LYMPHOCYTE-DEPENDENT ANTIBODY AND RENAL GRAFT REJECTIONSTILLER CR; SINCLAIR NRS; ABRAHAMS S et al.1975; LANCET; G.B.; DA. 1975; NO 7913; PP. 953-954; BIBL. 12REF.Article

IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN AKEOWN PA; STILLER CR; ULAN RA et al.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8222; PP. 686-689; BIBL. 13 REF.Article